Showing results (51-60 of 1,802) with videos related to

Sort By:
Pageof 181
Transplantation and Cellular Therapy|January 21, 2023
Ethical Challenges with Multiple Myeloma BCMA Chimeric Antigen Receptor T Cell Slot Allocation: A Multi-Institution ExperienceTaxiarchis Kourelis, Radhika Bansal, Jesus Berdeja, et al.
Transplantation and Cellular Therapy|January 22, 2023
T Cell-Depleted Peripheral Blood versus Unmanipulated Bone Marrow in Matched Sibling Transplantation for Aplastic AnemiaPedro Chorão, Juan Montoro, Aitana Balaguer-Roselló, et al.
Transplantation and Cellular Therapy|January 23, 2023
A Hematopoietic Stem Cell Transplantation Startup in Iraqi Kurdistan: Results in Thalassemia Patients and Analysis of the MethodologyMarta Verna, Marta Canesi, Valentino Conter, et al.
Transplantation and Cellular Therapy|July 27, 2021
Open-Label, Multicenter Phase II Study of Combination Therapy of Imatinib Mesylate and Mycophenolate Mofetil in Pediatric Patients with Steroid-Refractory Sclerotic/Fibrotic Type Chronic Graft-versus-Host DiseaseJung Yoon Choi, Hyery Kim, Hee Jo Baek, et al.
Transplantation and Cellular Therapy|July 28, 2021
Survival Advantage of Treosulfan Plus Fludarabine Before Allogeneic Hematopoietic Cell Transplantation for Older or Comorbid Patients With Myeloid MalignanciesIoanna Sakellari, Eleni Gavriilaki, Despina Mallouri, et al.
Transplantation and Cellular Therapy|August 29, 2025
The Impact of Anti-CD38 Monoclonal Antibody Therapy on Stem-Cell Mobilization Yields in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Referred from Community and Academic Oncology Practices: Single Center, Real World Data 2021-2024Dilek Uzun, Jeddeo Michael Paul, Alexandria Jensen, et al.
Transplantation and Cellular Therapy|September 6, 2025
Transient and Shear-Wave Elastography in the Detection of Hepatic Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-AnalysisLeticia Helena Kaca do Carmo, Maria Tamyres de Carvalho Freitas, Rafaella Baratta Colla, et al.
Transplantation and Cellular Therapy|August 27, 2025
Long-term efficacy of EBV-specific T cells for EBV-PTLD after allogeneic stem cell transplantation: a real word studyHai-Lu Sun, Qiang Fu, Xiang- Yu Zhao, et al.
Transplantation and Cellular Therapy|May 17, 2022
A Clinical Review of the Different Strategies to Minimize Hemorrhagic Cystitis Associated with the Use of Post-Transplantation Cyclophosphamide in an Allogeneic TransplantDat Ngo, Diana Samuels, Jason Chen, et al.
Transplantation and Cellular Therapy|May 17, 2022
Low Graft Invariant Natural Killer T-Cell Dose Is a Risk Factor for Cytomegalovirus Reactivation After Allogeneic Hematopoietic Cell TransplantationDominik Schneidawind, Silke Duerr-Stoerzer, Sonja Liewer, et al.
Pageof 181